|Articles|July 28, 2009
Retina Roundtable Session 4
Advertisement
Subscribe
In this fourth session, the physicians discuss their strategies for managing the flow of patients coming in each month to receive their ranibizumab injections.
Participants include:
Return to
Return to
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
2
EURETINA 2026: Predicting geographic atrophy progression with DARC
3
EURETINA 2026: Gene therapy sessions to watch in Vienna
4
Boosting premium IOL confidence through a mix-and-match approach
5












